SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Plowman R, Graves N, Esquivel J, Roberts JA. An economic model to assess the cost and benefits of the routine use of silver alloy coated urinary catheters to reduce the risk of urinary tract infections in catheterized patients. J Hosp Infect 2001; 48: 3342
  • 2
    National Institute for Health and Clinical Excellence. Infection prevention and control of healthcare-associated infections in primary and community care. NICE. CG 139. March 2012
  • 3
    National Institute for Health and Clinical Excellence. Clinical and cost effectiveness and NHS impact. National Institute for Health and Clinical Excellence ed., Guide to the Methods of Technology Appraisal. London: National Institute for Health and Clinical Excellence, 2008: 2751
  • 4
    Fenwick EA, Briggs AH, Hawke CI. Management of urinary tract infection in general practice: a cost-effectiveness analysis. Br J Gen Pract 2000; 50: 6359
  • 5
    Ginnelly L, Claxton K, Sculpher MJ, Golder S. Using value of information analysis to inform publicly funded research priorities. Appl Health Econ Health Policy 2005; 4: 3746
  • 6
    Turner D, Little P, Raftery J et al. Cost effectiveness of management strategies for urinary tract infections: results from randomised controlled trial. BMJ 2010; 340: c346
  • 7
    Whiting P, Westwood M, Bojke L et al. Clinical effectiveness and cost-effectiveness of tests for the diagnosis and investigtion of urinary tract infection in children: a systematic review and economic model. Health Technol Assess 2006; 10: iii154
  • 8
    Barry HC, Ebell MH, Hickner J. Evaluation of suspected urinary tract infection in ambulatory women: a cost-utility analysis of office-based strategies. J Fam Pract 1997; 44: 4960
  • 9
    Gold MR, Franks P, McCoy KI, Fryback DG. Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Med Care 1998; 36: 77892
  • 10
    Sonnenberg FA, Burkman RT, Hagerty CG, Speroff L, Speroff T. Costs and net health effects of contraceptive methods. Contraception 2004; 69: 44759
  • 11
    Ellis AK, Verma S. Quality of life in women with urinary tract infections: is benign disease a misnomer? J Am Board Fam Pract 2000; 13: 3927
  • 12
    Abrahamian FM, Krishnadasan A, Mower WR, Moran GJ, Coker JR, Talan DA. The association of antimicrobial resistance with cure and quality of life among women with acute uncomplicated cystitis. Infection 2011; 39: 50714
  • 13
    Ernst EJ, Ernst ME, Hoehns JD, Bergus GR. Women's quality of life is decreased by acute cystitis and antibiotic adverse effects associated with treatment. Health Qual Life Outcomes 2005; 3: 45
  • 14
    Maxwell CJ, Kang J, Walker JD et al. Sex differences in the relative contribution of social and clinical factors to the Health Utilities Index Mark 2 measure of health-related quality of life in older home care clients. Health Qual Life Outcomes 2009; 7: 80
  • 15
    Vogel LC, Krajci KA, Anderson CJ. Adults with pediatric-onset spinal cord injuries: part 3: impact of medical complications. J Spinal Cord Med 2002; 25: 297305
  • 16
    Vogel LC, Chlan K, Zebracki K, Anderson C. Long-term outcomes of adults with pediatric-onset spinal cord injuries as a function of neurological impairment. J Spinal Cord Med 2011; 34: 606
  • 17
    Zebracki K, Anderson C, Chlan K, Vogel LC. Outcomes of adults with paediatric-onset spinal cord injury: longditudinal findings and implications on transition to adulthood. Top Spinal Cord Inj Rehabil 2010; 16: 1725
  • 18
    Haran MJ, Lee BB, King MT, Marial O, Stockler MR. Health status rated with the Medical Outcomes Study 36-Item Short-Form Health Survey after spinal cord injury. Arch Phys Med Rehabil 2005; 86: 22905
  • 19
    Lee BB, King MT, Simpson JM et al. Validity, responsiveness, and minimal important difference for the SF-6D health utility scale in a spinal cord injured population. Value Health 2008; 11: 6808
  • 20
    Ara R, Brazier J. Deriving an algorithm to convert the eight mean SF-36 dimension scores into a mean EQ-5D preference-based score from published studies (where patient level data are not available). Value Health 2008; 7: 113143
  • 21
    Gray A, Rivero-Arias O, Clarke P. Estimating the association between SF-12 responses and EQ-5D utility values by response mapping. Med Decis Making 2006; 26: 1829
  • 22
    Brazier J, Roberts JA, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002; 21: 27192
  • 23
    Brazier J, Roberts JA. The estimation of a preference-based measure of health from the SF-12. Med Care 2004; 42: 8519
  • 24
    Ackerman SJ, Rein AL, Blute M et al. Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia. Part I: methods. Urology 2000; 56: 97280
  • 25
    Yen ZS, Davis MA, Chen SC, Chen WJ. A cost-effectiveness analysis of treatment strategies for acute uncomplicated pyelonephritis in women. Acad Emerg Med 2003; 10: 30914
  • 26
    Lawler FH, Bisonni RS, Holtgrave DR. Circumcision: a decision analysis of its medical value. Fam Med 1991; 23: 58793
  • 27
    Lee BB, Simpson JM, King MT, Haran MJ, Marial O. The SF-36 walk-wheel: a simple modification of the SF-36 physical domain improves its responsiveness for measuring health status change in spinal cord injury. Spinal Cord 2009; 47: 505
  • 28
    Health Economics Research Centre. SF-12 responses and EQ-5D utility values. 2011
  • 29
    Brazier J, Papaioannou D, Cantrell A, Paisley S, Herrmann K. Identifying and reviewing health state utility values for populating decision models. In Shemilt I, Mugford M, Vale L, Marsh K, Donaldson C eds, Evidence-Based Decisions and Economics: Health Care, Social Welfare, Education and Criminal Justice. Oxford: Wiley-Blackwell, 2010: 93104